MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/ofid/ofad386

Медицинская библиотека · Open forum infectious diseases · 2023

Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant.

Ariza-Heredia Ella J, Winston Drew J, Rowley Scott D, Mullane Kathleen, Chandrasekar Pranatharthi, Hari Parameswaran, Avery Robin K, Peggs Karl S, Kumar Deepali, Nath Rajneesh, Ljungman Per, Mossad Sherif B, El Haddad Lynn, Shah Dimpy P, Jiang Ying, Khawaja Fareed, Dadwal Sanjeet, Blanchard Ted, Chemaly Roy F

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Cytomegalovirus (CMV) infection is a common opportunistic infection after allogeneic hematopoietic cell transplant (alloHCT). We explored whether a change in CMV cell-mediated immunity during the first month after transplant predicts the risk of development of CMV infection and all-cause mortality.

METHODS

This follow-up analysis is based on data from the REACT study, a multicenter prospective observational study of recipients of alloHCT who were CMV-seropositive. Production of interferon γ following ex vivo stimulation with CMV antigens IE1 (immediate early 1) and pp65 (phosphoprotein 65) was assessed by CMV ELISPOT assay at baseline and 2 and 4 weeks after transplant. Clinically significant CMV infection (CS-CMVi) was defined as CMV viremia and/or disease necessitating antiviral therapy. We evaluated the impact of CMV CMI changes on the risk of CS-CMVi and post transplant mortality.

RESULTS

The analysis included 226 recipients of alloHCT with CMV cell-mediated immunity data at baseline and 2 and/or 4 weeks after transplant. CS-CMVi occurred in 64 patients (28%). On Cox regression analyses, independent predictors of CS-CMVi included a negative Δ change from baseline to week 2 of pp65 spot counts (hazard ratio, 3.65 [95% CI, 1.65-8.04]; P = .001) to week 4 of IE1 spot counts (hazard ratio, 2.79 [95% CI, 1.46-5.35]; P = .002), anti-thymocyte globulin conditioning regimen, type of transplant, female sex, and corticosteroid use. Kaplan-Meir analysis showed a significant association of a negative IE1 change from baseline to week 4 and increased all-cause mortality after transplant (log rank test = 0.041).

CONCLUSIONS

A decrease in CMV-specific T-cell responses during the first month after transplant may predict CS-CMVi and is associated with all-cause mortality in recipients of alloHCT.

Для цитирования: Ariza-Heredia Ella J, Winston Drew J, Rowley Scott D, Mullane Kathleen, Chandrasekar Pranatharthi, Hari Parameswaran, Avery Robin K, Peggs Karl S, Kumar Deepali, Nath Rajneesh, Ljungman Per, Mossad Sherif B, El Haddad Lynn, Shah Dimpy P, Jiang Ying, Khawaja Fareed, Dadwal Sanjeet, Blanchard Ted, Chemaly Roy F. Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant.. Open forum infectious diseases. 2023. DOI: 10.1093/ofid/ofad386.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.